Chiral drugs: an overview

About more than half of the drugs currently in use are chiral compounds and near 90% of the last ones are marketed as racemates consisting of an equimolar mixture of two enantiomers. Although they have the same chemical structure, most isomers of chiral drugs exhibit marked differences in biological...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of biomedical science Vol. 2; no. 2; pp. 85 - 100
Main Authors Nguyen, Lien Ai, He, Hua, Pham-Huy, Chuong
Format Journal Article
LanguageEnglish
Published United States Master Publishing Group 01.06.2006
Subjects
toxicology
chiral terms
chiral drugs
enantioselective antibodies
pharmacology
pharmacokinetics
metabolism
chiral separation
analysis
Online AccessGet full text

Cover

More Information
Summary:About more than half of the drugs currently in use are chiral compounds and near 90% of the last ones are marketed as racemates consisting of an equimolar mixture of two enantiomers. Although they have the same chemical structure, most isomers of chiral drugs exhibit marked differences in biological activities such as pharmacology, toxicology, pharmacokinetics, metabolism etc. Some mechanisms of these properties are also explained. Therefore, it is important to promote the chiral separation and analysis of racemic drugs in pharmaceutical industry as well as in clinic in order to eliminate the unwanted isomer from the preparation and to find an optimal treatment and a right therapeutic control for the patient. In this article, we review the nomenclature, pharmacology, toxicology, pharmacokinetics, metabolism etc of some usual chiral drugs as well as their mechanisms. Different techniques used for the chiral separation in pharmaceutical industry as well as in clinical analyses are also examined.
ISSN:1550-9702
1555-2810
DOI:10.59566/ijbs.2006.2085